|
Volume of disease (cm3; median, range)
|
249.5 (9.9–1505)
|
|---|
|
Uni/bilateral
|
|
Unilateral
|
7/106 (6.6%)
|
|
Bilateral
|
99/106 (93.4%)
|
|
Affected lobes
|
|
Only lower lobe(s)
|
5/106 (4.7%)
|
|
Lower lobe(s) + at least one other lobe
|
97/106 (91.5%)
|
|
No lower lobe involvement
|
4/106 (3.8%)
|
|
Gradient
|
|
Apicobasal gradient
|
49/106 (46.2%)
|
|
No apicobasal gradient
|
57/106 (53.8%)
|
|
Distribution
|
|
Peripheral
|
39/106 (36.8%)
|
|
Central
|
2/106 (1.9%)
|
|
Mixed
|
65/106 (61.3%)
|
|
CT pattern
|
|
Pure GGO
|
11/106 (10.4%)
|
|
GGO + septal thickening
|
46/106 (43.4%)
|
|
GGO + consolidation
|
49/106 (46.2%)
|
|
Predominant type
|
|
GGO
|
79/106 (74.5%)
|
|
Consolidation
|
27/106 (25.5%)
|
|
CT sign
|
|
Reverse halo
|
7/106 (6.6%)
|
|
Linear opacities
|
66/106 (62.3%)
|
|
Nodules
|
28/106 (26.4%)
|
|
Secondary findings
|
|
Emphysema
|
13/106 (12.3%)
|
|
Fibrosis
|
8/106 (7.5%)
|
|
Enlarged lymph nodes (≥ 10 mm short axis)
|
33/106 (31.1%)
|
|
Pleural effusion
|
10/106 (9.4%)
|
|
Pleural thickening
|
15/106 (14.15%)
|
|
Aortic Calcification
|
45/106 (42.5%)
|
|
Coronary calcification
|
53/106 (50.0%)
|
|
Other
|
|
Pneumomediastinum
|
1/106 (0.9%)
|
|
Iatrogenic pneumothorax and subcutaneous emphysema
|
1/106 (0.9%)
|
- GGO Ground-glass opacities
